Insulin Chemiluminescence ELISA

$451.00
Catalog
80-INSHU-CH01

The STELLUX® Chemi Human Insulin ELISA measures the concentration of insulin in human serum, heparin plasma, and tissue culture supernatants.

  • Broad dynamic range of 5–30,000 pg/mL
  • Superior sensitivity compared other products on the market. 
  • LOD: <2.0 pg/mL
  • LLOQ: 20 pg/mL
FDA Class I Device. For In Vitro Diagnostic Use.
Species
Human
Regulatory Status
FDA Class I Device. For In Vitro Diagnostic Use.
Product Distribution
Available Worldwide
Range
5 pg/mL - 30, 000 pg/mL
Sensitivity
2 pg/mL
Sizes
96 Wells
Sample Types
Heparin Plasma, Serum, Tissue Culture
Inc Time Hour
1
Inc Time Minute
35
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
25
Detection
Chemiluminescence

The STELLUX® Chemi Human Insulin ELISA measures the concentration of insulin protein products and offers superior performance compared to other similar kits in the market. The assay utilizes a dual-monoclonal antibody sandwich format, tri-level control set, and 96-well microplate comprising removable strips. The assay can measure up to 37 samples in duplicate and can be used in a variety of sample types.

Broad Dynamic Range (5 – 30,000 pg/mL)
Significantly reduces sample preparation time by eliminating dilution steps and the guesswork involved in determining dilution factors, saving time and money. No guessing, no diluting, no repeating.

Sensitivity
Superior assay sensitivity compared to current competitive products on the market. LOD: <2.0 pg/mL, with a lower limit of quantification of 20 pg/mL.

One Assay to Fit All Sample Types
The assay works with human serum, heparin plasma and tissue culture supernatants.

Lot Validation Package
Lot validation includes functional sensitivity, inter- and intra-assay precision, accuracy, LLOQ , and ULOQ.

Insulin Chemiluminescence ELISA

80-INSHU-CH01

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

ALPCO AAAAI 2024
ALPCO at 2024 American Academy of Allergy, Asthma & Immunology(AAAAI) Annual Meeting
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
View Now
Biomarker Monitoring for the Management of Crohn’s Disease
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in...
View Now
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic...
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.